Drugs Competitors

DMAA Stock   10.26  0.01  0.1%   
Drugs Made In competes with YHN Acquisition, CO2 Energy, CO2 Energy, Vine Hill, and Roman DBDR; as well as few others. The company conducts business under Industrials sector and is part of Shell Companies industry. Analyzing Drugs Made competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Drugs Made to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Drugs Made Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Drugs Made competition on your existing holdings.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
10.1510.2610.37
Details
Intrinsic
Valuation
LowRealHigh
8.478.5811.29
Details
Naive
Forecast
LowNextHigh
10.1710.2810.39
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.9110.2310.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Drugs Made. Your research has to be compared to or analyzed against Drugs Made's peers to derive any actionable benefits. When done correctly, Drugs Made's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Drugs Made In.

Drugs Made Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Drugs Made and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Drugs and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Drugs Made In does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
DRDBVCIC
NOEMWYHNAR
VCICYHNAR
VCICNOEMW
DRDBNOEMR
DRDBNOEMW
  
High negative correlations   
NOEMRYHNAR
DRDBYHNAR

Risk-Adjusted Indicators

There is a big difference between Drugs Stock performing well and Drugs Made Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Drugs Made's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Drugs Made Competitive Analysis

The better you understand Drugs Made competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Drugs Made's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Drugs Made's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
DMAA YHNAR NOEMR NOEMW VCIC DRDB
 0.1 
 10.26 
Drugs
 28.57 
 0.18 
YHN
 5.26 
 0.18 
CO2
 50.00 
 0.15 
CO2
 0.19 
 10.40 
Vine
 0.1 
 10.26 
Roman
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number Of Shares Shorted
Book Value Per Share
Return On Asset
Net Asset
EBITDA
Current Valuation
Total Asset
Retained Earnings
Short Ratio
Shares Owned By Institutions
Market Capitalization
Number Of Employees
Net Income
Shares Outstanding
Cash Flow From Operations
Total Debt
Shares Owned By Insiders
Working Capital
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Drugs Made Competition Performance Charts

Five steps to successful analysis of Drugs Made Competition

Drugs Made's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Drugs Made In in relation to its competition. Drugs Made's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Drugs Made in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Drugs Made's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Drugs Made In, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Drugs Made position

In addition to having Drugs Made in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds
Realty Funds Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Drugs Made In is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Drugs Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Drugs Made In Stock. Highlighted below are key reports to facilitate an investment decision about Drugs Made In Stock:
Check out Drugs Made Correlation with its peers.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Trading space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.